• Funds to Accelerate Medical Diagnostic Platform Development
    Junior Research Scientist Jake Cotterill, Research Scientist Lorea Orueta, Linear Diagnostics Ltd Chief Technology Officer Mathew Hicks, UK Innovation & Science Seed Fund Manager Oliver Sexton, Linear Diagnostics Ltd Chairman and CEO Brendon Farrell, Linear Diagnostics Ltd Non-Executive Director David Wilson, Midven Director Roger Wood, Senior Research Scientist Jean-Louis Duprey and British Business Bank Senior Funds Operation Manager Dave Tindall.

News

Funds to Accelerate Medical Diagnostic Platform Development

Birmingham spin-out Linear Diagnostics Ltd, has received £2m of investment to create a platform that is able to provide multiple diagnoses in a Point of Care environment.

The funding round was led by venture capital firm Midven, using equity finance from the Midlands Engine Investment Fund (MEIF). The round also included investment from the UK Innovation Science and Seed Fund, the University of Birmingham, Abingdon Health and the company’s directors.

Linear Diagnostics’ platform uses the disruption of polarised light to measure changes in DNA sequences, offering a rapid and low cost method to identify key gene sequences.

The firm’s first test of the platform will see it target sexually transmitted diseases. The ability to detect drug resistant infections and rapidly identify the causal agent allows screening and treatment during a single patient visit. The World Health Organisation has recognised this is not yet capable of being achieved using alternative diagnostic approaches – Linear Diagnostics’ platform will eventually be able to diagnose multiple genetic targets from a single sample within a 15 minute timescale.

LDL was formed in 2011 by its founders Professor Tim Dafforn and Dr Matt Hicks, based on their patented research in the field of Linear Diachroism – using polarised light to identify changes at a molecular level.

Matt Hicks, CTO and Founder of Linear Diagnostics Limited, said: “We’re at a really exciting stage of our development and this round of investment is a fantastic opportunity for us take our explorations and anaylsis to the next level. The funding will help us accelerate time to market of our initial product, through further investment in technical resource and beginning hardware development.”

The MEIF project is supported financially by the European Union using funding from the European Regional Development Fund (ERDF) as part of the European Structural and Investment Funds Growth Programme 2014-2020 and the European Investment Bank.


Digital Edition

Lab Asia Dec 2025

December 2025

Chromatography Articles- Cutting-edge sample preparation tools help laboratories to stay ahead of the curveMass Spectrometry & Spectroscopy Articles- Unlocking the complexity of metabolomics: Pushi...

View all digital editions

Events

Smart Factory Expo 2026

Jan 21 2026 Tokyo, Japan

Nano Tech 2026

Jan 28 2026 Tokyo, Japan

Medical Fair India 2026

Jan 29 2026 New Delhi, India

SLAS 2026

Feb 07 2026 Boston, MA, USA

Asia Pharma Expo/Asia Lab Expo

Feb 12 2026 Dhaka, Bangladesh

View all events